Yahoo Finance Top Ranked Growth Stocks to Buy for January 14th
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 14th:
Cimpress plc (CMPR): This mass customization services provider, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.
Cimpress N.V Price and Consensus
Cimpress N.V price-consensus-chart | Cimpress N.V Quote
Cimpress has a PEG ratio of 1.17 compared with 2.16 for the industry. The company possesses a Growth Score of A.
Cimpress N.V PEG Ratio (TTM)
Cimpress N.V peg-ratio-ttm | Cimpress N.V Quote
Focus Financial Partners Inc. (FOCS): This wealth management services provider, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
Focus Financial Partners Inc. Price and Consensus
Focus Financial Partners Inc. price-consensus-chart | Focus Financial Partners Inc. Quote
Focus Financial Partners has a PEG ratio of 0.49, compared with 1.28 for the industry. The company possesses a Growth Score of A.
Focus Financial Partners Inc. PEG Ratio (TTM)
Focus Financial Partners Inc. peg-ratio-ttm | Focus Financial Partners Inc. Quote
Berry Global Group, Inc. (BERY): This packaging solutions provider, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.
Berry Global Group, Inc. Price and Consensus
Berry Global Group, Inc. price-consensus-chart | Berry Global Group, Inc. Quote
Berry Global has a PEG ratio of 0.88, compared with 1.87 for the industry. The company possesses a Growth Score of B.
Berry Global Group, Inc. PEG Ratio (TTM)
Berry Global Group, Inc. peg-ratio-ttm | Berry Global Group, Inc. Quote
Arcosa, Inc. (ACA): This manufacturer and marketer of infrastructure-related products and services, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
Arcosa, Inc. Price and Consensus
Arcosa, Inc. price-consensus-chart | Arcosa, Inc. Quote
Arcosa has a PEG ratio of 1.40, compared with 1.43 for the industry. The company possesses a Growth Score of B.
Arcosa, Inc. PEG Ratio (TTM)
Arcosa, Inc. peg-ratio-ttm | Arcosa, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Focus Financial Partners Inc. (FOCS) : Free Stock Analysis Report
Cimpress N.V (CMPR) : Free Stock Analysis Report
Berry Global Group, Inc. (BERY) : Free Stock Analysis Report
Arcosa, Inc. (ACA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
